Graf Akcie HTBX (Heat Biologics Inc). Diskuze k akciím HTBX. Aktuální informace HTBX.

Základní informace o společnosti Heat Biologics Inc (Akcie HTBX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 148.32M
Hodnota podniku (EV) N/A
Tržby 2.451M
EBITDA N/A
Zisk -29.38
Růst v tržbách Q/Q -22.54 %
Růst v tržbách Y/Y -29.98 %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 16.69
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 60.51
P/FCF N/A
Price/Book 1.28
Účetní hodnota na akcii 4.60
Hotovost na akcii 4.43
FCF vůči ceně -18.02 %
Počet zaměstnanců 39
Tržba na zaměstnance 62.848k
Profit margin -883.65 %
Operating margin -1,224.78 %
Gross margin 100.00 %
EBIT margin -1,198.61 %
EBITDA margin -440.25 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -25.71 %
EPS - Očekávaný růst příští rok -28.57 %
Return on assets -21.88 %
Return on equity -23.20 %
ROIC -34.43 %
ROCE -21.69 %
Dluhy/Equity 0.07
Čistý dluh/EBITDA 10.37
Current ratio 37.22
Quick Ratio 37.22
Volatilita 3.80
Beta 0.62
RSI 42.32
Cílová cena analytiků 4
Známka akcie (dle analytiků) 1.00
Insider ownership 4.15 %
Institutional ownership 11.37 %
Počet akcií 25.397M
Procento shortovaných akcií 9.68 %
Short ratio 6.47 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2013
Země United States

Finanční výsledky akcie HTBX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$3.049$5.794$1.52$0.342--
Cost Of Goods Sold------
Gross Profit$3.049$5.794$1.52$0.342--
Research And Development Expenses$13.014$16.233$8.268$9.331$16.666$2.861
SG&A Expenses$9.431$7.025$6.371$4.138$4.356$3.978
Other Operating Income Or Expenses$-0.613$-0.496$-0.224--$-5.348
Operating Expenses$23.795$23.754$14.863$13.469$21.023$12.187
Operating Income$-20.746$-17.96$-13.343$-13.127$-21.023$-12.187
Total Non-Operating Income/Expense$0.406$0.384$0.123$0.153$-0.099$-0.056
Pre-Tax Income$-20.34$-17.577$-13.219$-12.975$-21.122$-12.243
Income Taxes$0.045$-0.986$-0.81---
Income After Taxes$-20.385$-16.591$-12.41$-12.975$-21.122$-12.243
Other Income------
Income From Continuous Operations$-20.385$-16.591$-12.41$-12.975$-21.122$-12.243
Income From Discontinued Operations------
Net Income$-20.018$-15.734$-11.842$-12.574$-20.295$-11.789
EBITDA$-19.776$-17.723$-13.209$-12.744$-20.663$-11.909
EBIT$-20.746$-17.96$-13.343$-13.127$-21.023$-12.187
Basic Shares Outstanding521000
Shares Outstanding521000
Basic EPS$-4.20$-6.30$-21.55$-50.03$-177.05$-128.06
EPS - Earnings Per Share$-4.20$-6.30$-21.55$-50.03$-177.05$-128.06
# 2020 2019 2018 2017 2016 2015
Current Ratio1.8035.89351.13635.17981.79545.944
Long-term Debt / Capital0.0107---0.59150.1734
Debt/Equity Ratio0.13460.0392--2.7040.2457
Gross Margin100100100100--
Operating Margin-680.3902-309.9893-877.8519-3842.408--
EBIT Margin-680.3902-309.9893-877.8519-3842.408--
EBITDA Margin-648.5939-305.8932-869.0302-3730.116--
Pre-Tax Profit Margin-667.0661-303.3697-869.7303-3797.765--
Net Profit Margin-656.5066-271.5613-779.0865-3680.436--
Asset Turnover0.11750.15340.07530.0384--
Inventory Turnover Ratio------
Receiveable Turnover87.1521203.0222102.47044.1509--
Days Sales In Receivables4.18811.79783.56287.9319--
ROE - Return On Equity-154.9243-54.86-214.6699-189.6919-846.6595-110.9772
Return On Tangible Equity-174.1463-59.1414-345.5276-189.6919-846.6602-110.9771
ROA - Return On Assets-78.5339-43.9343-61.467-145.84-159.7992-76.9226
ROI - Return On Investment-153.2626-54.86-214.6698-189.6919-345.8933-91.7354
Book Value Per Share2.72536.51359.63218.269220.7215118.8986
Operating Cash Flow Per Share5.99022.963142.149498.5125-45.757812.7619
Free Cash Flow Per Share6.19512.837342.220399.3381-41.798.7068